InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Pinto Joshua. Director active across 2 companies, notably Neumora Therapeutics, Inc.. Aggregated, 8 filings have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €489k. Activity tracked since 14 February 2024. The latest transaction was disclosed on 17 February 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Pinto Joshua is associated with Neumora Therapeutics, Inc. as President and with Metsera, Inc. as Director. Across 8 filings in total, the recent sampled filings between 2024-02-16 and 2026-02-19 show 0 EUR of purchases and 488776 EUR of sales, with the dominant transaction nature indicated as sale.